Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Efficacy of Wushaoshe Qufeng Tablet and leflunomide combination therapy in the management of rheumatoid arthritis, and its influence on incidence of adverse drug reactions

Zenghui Xin¹ , Xiangwei Zhang²

¹The Major of Rehabilitative Technology, Guangdong Lingnan Institute of Technology, Guangzhou, China; ²Traditional Chinese Medicine Department, Heyuan Hospital of Traditional Chinese Medicine, Heyuan, Guangdong, China.

For correspondence:- Zenghui Xin Email: xiangddknx1165@163.com Tel:+8613751771866

Accepted: 29 January 2022 Published: 28 February 2021

Citation: Xin Z, Zhang X. Efficacy of Wushaoshe Qufeng Tablet and leflunomide combination therapy in the management of rheumatoid arthritis, and its influence on incidence of adverse drug reactions. Trop J Pharm Res 2022; 21(2):401-407 doi: 10.4314/tjpr.v21i2.25

© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To study the effectiveness and safety of combined use of Wushaoshe Qufeng tablets and leflunomide in the treatment of rheumatoid arthritis patients.

Methods: A retrospective trial was conducted among 120 patients with rheumatoid arthritis hospitalized in Heyuan Hospital of Traditional Chinese Medicine, Heyuan, from February 2020 to February 2021. The patients were equally divided into study group (n = 60) and control group (n = 60). Both groups received conventional treatment. in addition, the control group received leflunomide, whereas the experimental group received Wushaoshe Qufeng tablets. The two groups were compared with respect to laboratory indicators, TCM syndrome scores, and adverse events.

Results: The post-treatment TCM syndrome scores was lower in the experimental group versus control group (p < 0.001). After treatment, the study group was superior to the control group in terms of their biochemical indicators (p < 0.001). Safety profile was better in the study group than in the control group (p < 0.05). Treatment effectiveness was significantly higher in the study group than in the control group (p < 0.05).

Conclusion: Combined treatment of rheumatoid arthritis patients with Wushaoshe Qufeng tablets and leflunomide shows improved biochemical indicators, mitigates clinical symptoms, and enhances treatment effectiveness. Moreover, the combination therapy is safe, and therefore, should be considered for the management of rheumatoid arthritis patients.

Keywords: Wushaoshe Qufeng Tablets, Leflunomide, Rheumatoid arthritis